Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (491-500 of 1,289) with videos related to

Pageof 129
Sort By:
Leukemia & Lymphoma|April 10, 2008
Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicatorsZhifeng Yu, Baohua Sun, Hagop M Kantarjian, et al.
Transfusion|November 1, 1989
Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusionL T Goodnough, J R Bravo, Y S Hsueh, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Gut|December 1, 1991
Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatmentJ McNulty, A Chua, J Keating, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic ReviewAntonio Barrera, Leandro F M Rezende, Angelo Sabag, et al.
Blood|January 10, 2015
Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemiaBetty Lamothe, Fabiola Cervantes-Gomez, Mariela Sivina, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Leukemia & Lymphoma|October 4, 2017
Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cellsHima V Vangapandu, Huiqin Chen, William G Wierda, et al.
Leukemia|October 27, 1997
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemiaS O'Brien, H Kantarjian, M Beran, et al.
Pageof 129

Showing results (491-500 of 1,289) with videos related to

Sort By:
Pageof 129
Leukemia & Lymphoma|April 10, 2008
Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicatorsZhifeng Yu, Baohua Sun, Hagop M Kantarjian, et al.
Transfusion|November 1, 1989
Red blood cell mass in autologous and homologous blood units. Implications for risk/benefit assessment of autologous blood crossover and directed blood transfusionL T Goodnough, J R Bravo, Y S Hsueh, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1988
The characteristics and outcome of patients with late relapse acute myelogenous leukemiaH M Kantarjian, M J Keating, R S Walters, et al.
Gut|December 1, 1991
Dissolution of cholesterol gall stones using methyltertbutyl ether: a safe effective treatmentJ McNulty, A Chua, J Keating, et al.
Healthcare (Basel, Switzerland)|January 11, 2024
Understanding the Causes of Frailty Using a Life-Course Perspective: A Systematic ReviewAntonio Barrera, Leandro F M Rezende, Angelo Sabag, et al.
Blood|January 10, 2015
Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemiaBetty Lamothe, Fabiola Cervantes-Gomez, Mariela Sivina, et al.
Cancer Research|December 1, 1977
A phase 1 and 2 trial of rubidazone in patients with acute leukemiaR S Benjamin, M J Keating, K B McCredie, et al.
Leukemia & Lymphoma|October 4, 2017
Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cellsHima V Vangapandu, Huiqin Chen, William G Wierda, et al.
Leukemia|October 27, 1997
Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemiaS O'Brien, H Kantarjian, M Beran, et al.
Pageof 129